It should be noted that the above mentioned first-generation prognostic gene signatures can refine the prognostication of patients with hormone receptor positive early-stage breast cancer, but not other subtypes of the disease; indeed, the two fundamental biological phenomena assessed through them are ER signalling and proliferation status. This evidence concerns the gene NR4A1 and breast carcinoma.